- Brendan Hayes, MPH, CPH, National Hemophilia Foundation senior director of education, innovative therapies
- Brad Schoenfeld, senior director, advocacy and professional relations, rare disease North America, Pfizer
- Maria Santaella, National Hemophilia Foundation VP of research strategy